AHA Scientific Sessions 2025 Abstract
EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics
Trial in peopleInterventions
Papers by Christopher Paul Cannon
1 result